Clinical Trials for Milestone Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Milestone Pharmaceuticals

Clinical Trials (3)

NCT06716021
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
PHASE3Not yet recruiting
750 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2029
1 condition1 sponsor0 locations
NCT05763953
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
PHASE2Recruiting
60 participants
Started: Dec 11, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor10 locations
NCT04952610
Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
PHASE3Enrolling by invitation
130 participants
Started: Dec 13, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor23 locations